Free Press Journal
  • New HIV drug effectively reduces virus, boosts immunity: Study

    New York: A new intravenous HIV drug has shown to be effective in reducing virus, boost immunity among patients with advanced, multi-drug resistant HIV infection, results of a phase-III trial has showed. As the first monoclonal antibody approved by the US Food and Drug Administration (FDA) in March 2018 to treat HIV, ibalizumab is a promising option for individuals who have tried several other drug therapies. Ibalizumab targets the primary receptor for HIV

  • between sheets Pic: breelondon.com

    HIV drug blocks transferral even in condomless sex

    New York: HIV-affected people taking medication are highly unlikely to transmit the virus to their partners even if they have unprotected sex, suggests new research, according to IANS. The risk is especially low for straight couples, according to the study. For the study, published in the Journal of the American Medical Association (JAMA), the researchers followed 900 straight and gay couples.